Multiple Primary and Histology Rules 101 - PowerPoint PPT Presentation

1 / 59
About This Presentation
Title:

Multiple Primary and Histology Rules 101

Description:

When and how to use the rules. Why site-specific rules are necessary ... Cytology report. Documentation in the medical record that references pathology or cytology ... – PowerPoint PPT presentation

Number of Views:260
Avg rating:3.0/5.0
Slides: 60
Provided by: carol391
Category:

less

Transcript and Presenter's Notes

Title: Multiple Primary and Histology Rules 101


1
Multiple Primary and Histology Rules 101
  • Introductory Workshop
  • May 23, 2006
  • Pamela Moats, RHIT CTR
  • NCRA-SEER
  • HISTOLOGY LIASION

2
Overview
  • The problem with current rules
  • Overview of changes
  • Format of new rules
  • When and how to use the rules
  • Why site-specific rules are necessary

3
Whats the Problem?
  • 25 year old rules
  • Site-specific exceptions
  • Difficult to train
  • Could not flowchart
  • ICD-O-3
  • New terms and new codes
  • Non standard usage of nomenclature

4
Whats the Problem?
  • Changes in clinical practice
  • Technology advances
  • More histology characteristics descriptors
  • Electron microscopy to immunohistochemistry

5
Purpose of New Rules
  • Clarify rules
  • Prioritize sequence of rules
  • Explain, define terms
  • Promote consistency in coding
  • Same answer from registrar to registrar
  • Preserve integrity of incidence count
  • Improve quality of data overall

6
Major Changes
  • Multiple Primaries
  • Time frame
  • 2 months 1 year or 3 years
  • Histology
  • Take information only from the FINAL diagnosis
    and not the microscopic description
  • Rules for use of complex/combination codes

7
Primary Sites
  • Lung
  • Colon
  • Breast
  • Kidney
  • Renal pelvis, ureter, and bladder
  • Head and neck
  • Melanoma
  • Brain

35
17
8
How often do new rules apply?
  • Varies by site
  • Multiple Primaries lt10
  • gt 90 of cases are single primaries
  • Histology 15-25
  • 75-85 of cases are basic NOS terms
  • adenocarcinoma, ductal carcinoma, etc.

9
Content of Rules Documents
  • General Instructions
  • Site-Specific Rules
  • Equivalent Terms and Definitions
  • Multiple Primary Rules--three formats
  • Notes and examples
  • Histology Rules--three formats
  • Notes and examples
  • General rules
  • Same content and formats as site-specific rules

10
General Terms and Definitions
  • Read and know!
  • Use for all cases with the exception of
    hematopoietic primaries (leukemia and lymphoma)
  • Use only for multiple primary and histology rules
  • Not for casefinding

11
General Terms and Definitions
  • Bilateral
  • Clinical Diagnosis
  • Contiguous tumor
  • Contralateral
  • Different histology
  • Different (multiple) primaries
  • Focal
  • Foci
  • Focus
  • Ipsilateral
  • Most representative specimen
  • Multiple primaries
  • Overlapping tumor
  • Recurrence
  • Paired organ/site
  • Single histology
  • Single (one) primary
  • Unilateral

12
General Terms and Definitionscontinued
  • Focal-Foci-Focus
  • Focal limited to one specific area
  • May be microscopic or macroscopic
  • NOT a synonym of (microscopic) focus
  • Foci plural form of focus
  • Focus group of cells that can only be seen
    through a microscope

13
General Terms and Definitionscontinued
  • Most representative specimen
  • The pathologic specimen from the surgical
    procedure that removed the most tumor tissue.
  • Might be excisional biopsy rather than
  • -ectomy specimen

14
General Terms and Definitionscontinued
  • Recurrence
  • 1. A new or another occurrence, incidence,
    episode, or report of the disease in a more
    general sense a new occurrence of cancer.
  • 2. The reappearance of disease that was thought
    to be cured or inactive (in remission).
    Recurrent cancer starts from cancer cells that
    were not removed or destroyed by the original
    therapy.

15
General Terms and Definitionscontinued
  • Recurrence continued
  • Do not use a physicians statement to decide
    whether the patient has a recurrence of a
    previous cancer or a new primary.
  • Use the multiple primary rules as written
  • unless a pathologist compares the present tumor
    to the original tumor and states that this
    tumor is a recurrence of the previous primary.

16
In Addition
  • Read the site-specific Equivalent Terms and
    Definitions before using the site-specific
    multiple primary rules.

17
How to Use the Rules
  • Read equivalent terms and definitions
  • Choose a format of new rules to use
  • Text
  • Matrix
  • Flowchart

The rules are identical, only the formats differ.
18
Text
  • Multiple Primaries example
  • M2. A single independent non-metastatic tumor is
    always a single primary.
  • Note The tumor may overlap onto or extend
  • into adjacent/contiguous site or subsite.
  • Histology example
  • H4. Code the invasive histologic type when a
    single tumor has invasive and in situ components.

19
Matrix
Multiple Primaries example
Histology example
20
Flowchart--multiple primaries example
21
Flowchart--histology example
22
Flowchart
23
Learning Styles
  • Text
  • Flowchart
  • Matrix
  • Visual
  • Auditory
  • Read/Write
  • Kinesthetic

Use what works for you!
24
Warning!
  • Dont try to use all three rules formats!
  • Dont combine new rules with old rules!

25
Using the Rules
  • Notes and examples are included with some of the
    rules to highlight key points or to add clarity
    to the rules.
  • They are not exclusive.
  • They do not replace the rules.

26
Using the Rules
  • Use multiple primary rules first
  • Three independent modules
  • Unknown number of tumors
  • Single or multiple in primary site
  • Single tumor (primary site)
  • Multiple tumors (primary site)
  • Ask how many tumors does this case have?

27
Independent Modules
  • Start with rules in appropriate module.
  • Do not use rules from any other module.

28
Rules are Hierarchical
  • Within each section
  • Use the first rule that applies and STOP.

29
Histology Coding Rules
  • Two independent modules
  • Single Tumor (one primary site)
  • Multiple Tumors abstracted as a single primary
    site
  • Rules are hierarchical within each module.

30
Multiple Pathology Reports
  • Code from the pathology report
  • from the most representative specimen examined
  • from the final diagnosis

31
Pathology Reports
  • Note 1 A revised/amended diagnosis replaces the
    original final diagnosis. Code the histology from
    the revised/amended diagnosis.
  • Note 2 The new rules limit the information to
    the final diagnosis. The old rules allowed
    coding from information in the microscopic
    description.

32
If No Pathology
  • Cytology report
  • Documentation in the medical record that
    references pathology or cytology

33
Ambiguous Terms-No Longer Utilized
  • Apparent(ly)
  • Appears
  • Comparable with
  • Compatible with
  • Consistent with
  • Favor(s)
  • Most likely
  • Presumed
  • Probable
  • Suspect(ed)
  • Suspicious (for)
  • Typical (of)

34
No Negative Lists
  • If it isnt listed, dont code it.
  • No Do not use ambiguous terms list
  • No Terms that do not represent the majority of
    the tumor list

35
When?
  • The rules are effective for cases diagnosed
    January 1, 2007 and after.
  • Do not use these rules to abstract cases
    diagnosed prior to January 1, 2007.

36
Important!
  • The 2007 multiple primary rules replace all
    previous multiple primary rules.

37
Why Site-Specific Rules?
  • General rules cannot address site-specific issues
  • Histologies
  • Disease process for that site
  • Valid mixed and combination histology codes

38
Colon
  • Multiple tumors/polyps
  • Contiguous/overlapping sites
  • Time between diagnoses
  • NOS versus specific histology
  • Mucinous adenocarcinoma
  • Neuroendocrine carcinoma
  • Signet ring cell adenocarcinoma
  • Undifferentiated carcinoma
  • Adenocarcinoma with mixed subtypes

39
Head and Neck
  • What is the primary site?
  • Complex anatomy
  • Laterality
  • Paired site
  • Upper/lower
  • Field effect
  • Multiple tumors
  • Contiguous/overlapping sites

40
Head and Neck
  • Site Group new concept
  • Multiple reports
  • Multiple biopsies
  • Biopsy versus resection
  • Multiple resections
  • In situ and invasive
  • Time between diagnoses
  • Histology Group new concept

41
Lung
  • Laterality
  • Multiple tumors
  • Tumors with/without biopsy
  • Multiple reports
  • Contiguous/overlapping sites
  • Time between diagnoses

42
Lung (continued)
  • Multiple tumors in same lung but only one
    biopsied
  • Rules default to abstracting case as a single
    primary with metastatic disease when only one
    tumor is biopsied.
  • Three or more tumors in one or both lungs are
    usually a single lung primary with metastatic
    disease.

43
Lung (continued)
  • NOS versus specific histology
  • Histology codes the same at 3 digit level
  • Small cell (8041-8045) / non-small cell (8046)
  • Bronchoalveolar (8250-8254) / mixed (8255)
  • Histology Group new concept Chart I
  • Mixed histologies Table I

44
Melanoma
  • ICD-O-3 topography codes
  • Laterality-related issues
  • Right/left/midline
  • Front/back
  • Upper/lower
  • Precancerous lesions
  • Atypical melanocytic hyperplasia
  • Melanocytic intraepithelial neoplasia
  • Evolving melanoma

45
Melanoma
  • In situ melanoma
  • In situ and invasive melanoma
  • Time between diagnoses
  • Regressing melanoma
  • Recurrence
  • Effect on incidence counts and rates
  • Histology coding is pretty simple

46
Breast
  • TOO MANY TERMS
  • In situ subtypes
  • Invasive subtypes
  • In situ and invasive together
  • Recurrence
  • NOS versus specific histology
  • Combination histologies

47
Breast
  • Paget disease
  • Lobular and ductal carcinoma
  • Inflammatory carcinoma

48
Kidney
  • Similar to lung
  • Laterality
  • Easy to understand
  • Renal pelvis clearly part of lower urinary tract
  • Histology coding is pretty simple
  • NOS versus specific histology

49
Renal Pelvis, Ureter, Bladder
  • Laterality
  • Field effect or implantation
  • Multiple tumors
  • Transitional epithelium / urothelium
  • Papillary CA of low malignant potential
  • Papillary carcinoma - grade I/III
  • Papilloma

50
Renal Pelvis, Ureter, Bladder
  • Papillary versus flat tumor
  • In situ versus non-invasive
  • In-situ and invasive
  • Non-invasive and invasive
  • Time interval between diagnoses

51
Brain and Central Nervous System
  • What is the primary site?
  • Complex anatomy
  • Site Group new concept
  • Time between diagnoses
  • Benign/borderline/malignant

52
Brain and Central Nervous System
  • TOO MANY TERMS
  • Progression of disease histologic type
  • Histology Group new concept
  • Mixed histology

53
Highlights of General Rules
54
General Rules
  • Similar to site-specific rules
  • Address remaining combination and mixed histology
    issues
  • Cover all malignant solid tumors without
    site-specific rules
  • Exclude hematopoietic
  • Exclude Kaposi sarcoma
  • Exclude benign

55
General Rules
  • Multiple primary and histology
  • Three formats
  • Text, flowchart, matrix
  • Independent modules
  • Unknown Number of Tumors (MP only)
  • Single Tumor (primary site)
  • Multiple Tumors (primary site)

56
General Multiple Primary Rules
  • A single tumor is a single primary
  • Prostate single primary
  • Kaposi sarcoma single primary
  • Retinoblastoma single primary
  • Ovary bilateral at diagnosis single primary
  • Thyroid papillary and follicular at diagnosis
    single primary

57
General Histology Rules
  • In situ tumor only
  • Invasive and in situ tumor
  • Invasive tumor only
  • NOS and specific histology
  • Combination histology codes table

58
Project Timeline
  • February 2006 New Rules Field Trial
  • September 2006 Train the Trainers II
  • January 1, 2007 Implementation
  • The 2007 rules will replace all previous rules

59
Further Education 2006-2007
  • Additional training materials published on web
  • Webcasts
  • State meetings
  • NCRA meetings
Write a Comment
User Comments (0)
About PowerShow.com